SCHEMBL5159968

SCHEMBL5159968

CSc1nnc(NCc2n[nH]c(=O)c3ccccc23)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ MAPT P10636 4/20 0.52
▸ GAA P10253 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ BLM P54132 1/20 0.52
▸ LMNA P02545 2/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ POLB P06746 2/20 0.46
▸ PRMT5 O14744 1/20 0.46
▸ AR P10275 5/20 0.44
▸ PARP1 P09874 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163926 0.73 MAPT (0.64) KMT2AHIF1AMAPTGAAHTT
SCHEMBL5165966 0.73 MAPT (0.78) KMT2AHIF1AMAPTGAAHTT
SCHEMBL30231202 0.70 PRMT5 (0.68) ALDH1A1LMNASMN1; SMN2POLBPRMT5
SCHEMBL7462930 0.70 PRMT5 (0.68) ALDH1A1LMNASMN1; SMN2POLBPRMT5
SCHEMBL5160111 0.69 MAPT (0.75) KMT2AHIF1AMAPTGAAHTT
SCHEMBL5160240 0.69 MAPT (1.00) KMT2AHIF1AMAPTGAAHTT
SCHEMBL5162085 0.68 KMT2A (0.64) KMT2AHIF1AMAPTGAAHTT
SCHEMBL5161752 0.68 MAPT (1.00) KMT2AHIF1AMAPTGAAHTT
SCHEMBL4713932 0.68 SMN1; SMN2 (0.61) KMT2AHIF1AMAPTGAAHTT
SCHEMBL13858810 0.66 KDM4E (0.66) KMT2AHIF1AMAPTGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1231982-B1 USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ABBOTT GMBH & CO KG (DE) 2007-03-21 — — EP disclosed
US-6903098-B1 Use of phthalazine derivatives ABBOTT GMBH & CO. (DE) 2005-06-07 — — US disclosed
Send feedback